294 related articles for article (PubMed ID: 32785828)
1. Immunomodulatory effect of diallyl sulfide on experimentally-induced benign prostate hyperplasia via the suppression of CD4+T/IL-17 and TGF-β1/ERK pathways.
Elbaz EM; Amin HAA; Kamel AS; Ibrahim SM; Helmy HS
Inflammopharmacology; 2020 Oct; 28(5):1407-1420. PubMed ID: 32785828
[TBL] [Abstract][Full Text] [Related]
2. Chrysophanic acid reduces testosterone-induced benign prostatic hyperplasia in rats by suppressing 5α-reductase and extracellular signal-regulated kinase.
Youn DH; Park J; Kim HL; Jung Y; Kang J; Jeong MY; Sethi G; Seok Ahn K; Um JY
Oncotarget; 2017 Feb; 8(6):9500-9512. PubMed ID: 27880726
[TBL] [Abstract][Full Text] [Related]
3. Asteris Radix et Rhizoma suppresses testosterone-induced benign prostatic hyperplasia in rats by regulating apoptosis and inflammation.
Rho J; Seo CS; Park HS; Jeong HY; Moon OS; Seo YW; Son HY; Won YS; Kwun HJ
J Ethnopharmacol; 2020 Jun; 255():112779. PubMed ID: 32209388
[TBL] [Abstract][Full Text] [Related]
4. Psoralea corylifolia L. extract ameliorates benign prostatic hyperplasia by regulating prostate cell proliferation and apoptosis.
Kim HJ; Jin BR; An HJ
J Ethnopharmacol; 2021 Jun; 273():113844. PubMed ID: 33485982
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of combination of Stauntonia hexaphylla and Cornus officinalis on testosterone-induced benign prostatic hyperplasia through inhibition of 5α- reductase type 2 and induced cell apoptosis.
Karunasagara S; Hong GL; Jung DY; Kim KH; Cho K; Jung JY
PLoS One; 2020; 15(8):e0236879. PubMed ID: 32790676
[TBL] [Abstract][Full Text] [Related]
6. Effect of
Choi YJ; Kim EK; Fan M; Tang Y; Hwang YJ; Sung SH
Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31591335
[No Abstract] [Full Text] [Related]
7. Quisqualis indica Improves Benign Prostatic Hyperplasia by Regulating Prostate Cell Proliferation and Apoptosis.
Ub Wijerathne C; Park HS; Jeong HY; Song JW; Moon OS; Seo YW; Won YS; Son HY; Lim JH; Yeon SH; Kwun HJ
Biol Pharm Bull; 2017 Dec; 40(12):2125-2133. PubMed ID: 28943529
[TBL] [Abstract][Full Text] [Related]
8. Protective role of diosmin against testosterone propionate-induced prostatic hyperplasia in Wistar rats: Plausible role of oxidative stress and inflammation.
Vafa A; Afzal SM; Barnwal P; Rashid S; Shahid A; Alpashree ; Islam J; Sultana S
Hum Exp Toxicol; 2020 Sep; 39(9):1133-1146. PubMed ID: 31797688
[TBL] [Abstract][Full Text] [Related]
9. Kolaviron modulates angiogenesis, apoptosis and inflammatory signaling in rat model of testosterone propionate-induced benign prostate hyperplasia.
Farombi EO; Ajayi BO; Opata EK; Fafioye AO; Akinade AT
Inflammopharmacology; 2023 Aug; 31(4):2121-2131. PubMed ID: 36881348
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory Effect of Artemisinin on Testosterone Propionate Induced Benign Prostatic Hyperplasia.
Solanki A; Patel S; Solanki N; Shah U
Curr Drug Discov Technol; 2021; 18(4):518-524. PubMed ID: 32532194
[TBL] [Abstract][Full Text] [Related]
11. Dapoxetine attenuates testosterone-induced prostatic hyperplasia in rats by the regulation of inflammatory and apoptotic proteins.
Sayed RH; Saad MA; El-Sahar AE
Toxicol Appl Pharmacol; 2016 Nov; 311():52-60. PubMed ID: 27687055
[TBL] [Abstract][Full Text] [Related]
12. Berberine Improves Benign Prostatic Hyperplasia via Suppression of 5 Alpha Reductase and Extracellular Signal-Regulated Kinase
Youn DH; Park J; Kim HL; Jung Y; Kang J; Lim S; Song G; Kwak HJ; Um JY
Front Pharmacol; 2018; 9():773. PubMed ID: 30061836
[TBL] [Abstract][Full Text] [Related]
13. Canagliflozin alleviates experimentally induced benign prostate hyperplasia in a rat model: exploring potential mechanisms involving mir-128b/EGFR/EGF and JAK2/STAT3 signaling pathways through in silico and in vivo investigations.
Elbaz EM; Darwish A; Gad AM; Abdel Rahman AAS; Safwat MH
Eur J Pharmacol; 2023 Oct; 957():175993. PubMed ID: 37598927
[TBL] [Abstract][Full Text] [Related]
14. Protocatechuic acid ameliorates testosterone-induced benign prostatic hyperplasia through the regulation of inflammation and oxidative stress in castrated rats.
Akanni OO; Owumi SE; Olowofela OG; Adeyanju AA; Abiola OJ; Adaramoye OA
J Biochem Mol Toxicol; 2020 Aug; 34(8):e22502. PubMed ID: 32227675
[TBL] [Abstract][Full Text] [Related]
15. Combined effect of the finasteride and doxazosin on rat ventral prostate morphology and physiology.
Justulin LA; Acquaro C; Carvalho RF; Silva MD; Felisbino SL
Int J Androl; 2010 Jun; 33(3):489-99. PubMed ID: 19490185
[TBL] [Abstract][Full Text] [Related]
16. Cynanchum wilfordii Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Regulating 5α-Reductase and Androgen Receptor Activities in a Rat Model.
Lee G; Shin J; Choi H; Jo A; Pan S; Bae D; Lee Y; Choi C
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28953224
[TBL] [Abstract][Full Text] [Related]
17. Effects of Lespedeza Cuneata aqueous extract on testosterone-induced prostatic hyperplasia.
Park BK; Kim CW; Kwon JE; Negi M; Koo YT; Lee SH; Baek DH; Noh YH; Kang SC
Pharm Biol; 2019 Dec; 57(1):90-98. PubMed ID: 30724641
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of testosterone-induced benign prostatic hyperplasia using febuxostat in rats: The role of VEGF/TGFβ and iNOS/COX-2.
Abdel-Aziz AM; Gamal El-Tahawy NF; Salah Abdel Haleem MA; Mohammed MM; Ali AI; Ibrahim YF
Eur J Pharmacol; 2020 Dec; 889():173631. PubMed ID: 33031799
[TBL] [Abstract][Full Text] [Related]
19. Effect of Veratrum maackii on Testosterone Propionate-Induced Benign Prostatic Hyperplasia in Rats.
Park HS; Seo CS; Wijerathne CU; Jeong HY; Moon OS; Seo YW; Won YS; Son HY; Lim JH; Kwun HJ
Biol Pharm Bull; 2019 Jan; 42(1):1-9. PubMed ID: 30381617
[TBL] [Abstract][Full Text] [Related]
20. Umbelliferone Ameliorates Benign Prostatic Hyperplasia by Inhibiting Cell Proliferation and G1/S Phase Cell Cycle Progression through Regulation of STAT3/E2F1 Axis.
Kim HJ; Jin BR; An HJ
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
